| 期刊簡介 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Perioperative Medicine LetPub Score 5.9
50 ratings
Rate
Reputation 7.1 Influence 4.4 Speed 9.1 | ||||||||||||||||
| 期刊簡稱 | PERIOPER MED-LONDON | ||||||||||||||||
| ISSN | 2047-0525 | ||||||||||||||||
| h-index | N.A. | ||||||||||||||||
| CiteScore | N.A. | ||||||||||||||||
| 自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||
| 官方網站 | https://www.springer.com/journal/13741 | ||||||||||||||||
| 在線稿件提交 | https://www.editorialmanager.com/PERI | ||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||
| 出版商 | BioMed Central | ||||||||||||||||
| 主題領域 | Multiple | ||||||||||||||||
| 出版國/地區 | ENGLAND | ||||||||||||||||
| 發行頻率 | |||||||||||||||||
| 創刊年 | 2012 | ||||||||||||||||
| 每年文章數 | 116每年文章數趨勢 | ||||||||||||||||
| 黃金OA百分比 | 99.57% | ||||||||||||||||
OA Related Info | APC: No APC waiver：No Other charges: No Keywords: perioperative、medicine、anaesthesia Useful LinksAims & ScopeAuthor InstructionsEditorial BoardDouble anonymous peer review | ||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q2
| ||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2047-0525%5BISSN%5D | ||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 10 Weeks | ||||||||||||||||
| 競爭力 * | 來自作者的數據: | ||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [Perioperative Medicine] 的評論 | 撰寫評論 |
| 作者: swailwon 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-08-28 00:27:03 評論於 It took four and a half months to receive, with feedback from six reviewers. The content was revised twice as long as the original text, but fortunately it was finally accepted. The publication fee was $2990, which is relatively expensive with average value for money. However, the self-citation is low, the publication rate is low, but still acceptable.  (0) 讚！ | swailwon  |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us